Most-Cited Articles as of May 1, 2012 -- updated monthly

Rankings based on citations to online articles from HighWire-hosted articles.

    • S Moncada,
    • R M Palmer,
    • and E A Higgs
    Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev June 1991 43:109-142
  2. Review:
    • Vera Ralevic and
    • Geoffrey Burnstock
    Receptors for Purines and Pyrimidines Pharmacol Rev September 1, 1998 50:413-492
  3. Review:
    • Raymond Dingledine,
    • Karin Borges,
    • Derek Bowie,
    • and Stephen F. Traynelis
    The Glutamate Receptor Ion Channels Pharmacol Rev March 1, 1999 51:7-62
  4. Review:
    • Stephen S. G. Ferguson
    Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling Pharmacol Rev March 1, 2001 53:1-24
    • P B Timmermans,
    • P C Wong,
    • A T Chiu,
    • W F Herblin,
    • P Benfield,
    • D J Carini,
    • R J Lee,
    • R R Wexler,
    • J A Saye,
    • and R D Smith
    Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev June 1993 45:205-251
    • R A Coleman,
    • W L Smith,
    • and S Narumiya
    International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev June 1994 46:205-229
  7. Review:
    • M. de Gasparo,
    • K. J. Catt,
    • T. Inagami,
    • J. W. Wright,
    • and Th. Unger
    International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol Rev September 1, 2000 52:415-472
  8. Review:
    • Philip M. Murphy,
    • Marco Baggiolini,
    • Israel F. Charo,
    • Caroline A. Hébert,
    • Richard Horuk,
    • Kouji Matsushima,
    • Louis H. Miller,
    • Joost J. Oppenheim,
    • and Christine A. Power
    International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors Pharmacol Rev March 1, 2000 52:145-176
    • K D Bhoola,
    • C D Figueroa,
    • and K Worthy
    Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev March 1992 44:1-80
    • G M Rubanyi and
    • M A Polokoff
    Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev September 1994 46:325-415
    • D Hoyer,
    • D E Clarke,
    • J R Fozard,
    • P R Hartig,
    • G R Martin,
    • E J Mylecharane,
    • P R Saxena,
    • and P P Humphrey
    International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev June 1994 46:157-203
  12. Review:
    • Bertil B. Fredholm,
    • Adriaan P. IJzerman,
    • Kenneth A. Jacobson,
    • Karl-Norbert Klotz,
    • and Joel Linden
    International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol Rev December 1, 2001 53:527-552
  13. Review:
    • Arpad Szallasi and
    • Peter M. Blumberg
    Vanilloid (Capsaicin) Receptors and Mechanisms Pharmacol Rev June 1, 1999 51:159-212
    • B B Fredholm,
    • M P Abbracchio,
    • G Burnstock,
    • J W Daly,
    • T K Harden,
    • K A Jacobson,
    • P Leff,
    • and M Williams
    Nomenclature and classification of purinoceptors. Pharmacol Rev June 1994 46:143-156
    • P Holzer
    Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev June 1991 43:143-201
  16. Review:
    • Scott R. Macfarlane,
    • Michael J. Seatter,
    • Toru Kanke,
    • Gary D. Hunter,
    • and Robin Plevin
    Proteinase-Activated Receptors Pharmacol Rev June 1, 2001 53:245-282
    • W Sieghart
    Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev June 1995 47:181-234
  18. Review:
    • Rhian M. Touyz and
    • Ernesto L. Schiffrin
    Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol Rev December 1, 2000 52:639-672
  19. Review:
    • Kimberly A. Lucas,
    • Giovanni M. Pitari,
    • Shiva Kazerounian,
    • Inez Ruiz-Stewart,
    • Jason Park,
    • Stephanie Schulz,
    • Kenneth P. Chepenik,
    • and Scott A. Waldman
    Guanylyl Cyclases and Signaling by Cyclic GMP Pharmacol Rev September 1, 2000 52:375-414
  20. Review:
    • A. C. Howlett,
    • F. Barth,
    • T. I. Bonner,
    • G. Cabral,
    • P. Casellas,
    • W. A. Devane,
    • C. C. Felder,
    • M. Herkenham,
    • K. Mackie,
    • B. R. Martin,
    • R. Mechoulam,
    • and R. G. Pertwee
    International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors Pharmacol Rev June 1, 2002 54:161-202; doi:10.1124/pr.54.2.161
  21. Review:
    • E. A. Barnard,
    • P. Skolnick,
    • R. W. Olsen,
    • H. Mohler,
    • W. Sieghart,
    • G. Biggio,
    • C. Braestrup,
    • A. N. Bateson,
    • and S. Z. Langer
    International Union of Pharmacology. XV. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure and Receptor Function Pharmacol Rev June 1, 1998 50:291-314
  22. Review:
    • Babak Razani,
    • Scott E. Woodman,
    • and Michael P. Lisanti
    Caveolae: From Cell Biology to Animal Physiology Pharmacol Rev September 1, 2002 54:431-467; doi:10.1124/pr.54.3.431
  23. Review:
    • Elisabeth Falkenstein,
    • Hanns-Christian Tillmann,
    • Michael Christ,
    • Martin Feuring,
    • and Martin Wehling
    Multiple Actions of Steroid Hormones—A Focus on Rapid, Nongenomic Effects Pharmacol Rev December 1, 2000 52:513-556
  24. Review:
    • Shokei Kim and
    • Hiroshi Iwao
    Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol Rev March 1, 2000 52:11-34
    • W Linz,
    • G Wiemer,
    • P Gohlke,
    • T Unger,
    • and B A Schölkens
    Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev March 1995 47:25-49
  26. Review:
    • Malcolm P. Caulfield and
    • Nigel J. M. Birdsall
    International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors Pharmacol Rev June 1, 1998 50:279-290
  27. Review:
    • A. E. Aplin,
    • A. Howe,
    • S. K. Alahari,
    • and R. L. Juliano
    Signal Transduction and Signal Modulation by Cell Adhesion Receptors: The Role of Integrins, Cadherins, Immunoglobulin-Cell Adhesion Molecules, and Selectins Pharmacol Rev June 1, 1998 50:197-264
    • D Regoli and
    • J Barabé
    Pharmacology of bradykinin and related kinins. Pharmacol Rev March 1980 32:1-46
  29. Review:
    • David Vaudry,
    • Bruno J. Gonzalez,
    • Magali Basille,
    • Laurent Yon,
    • Alain Fournier,
    • and Hubert Vaudry
    Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol Rev June 1, 2000 52:269-324
  30. Review:
    • László Virág and
    • Csaba Szabó
    The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors Pharmacol Rev September 1, 2002 54:375-429; doi:10.1124/pr.54.3.375
  31. Review:
    • Anthony J. Harmar,
    • Akira Arimura,
    • Illana Gozes,
    • Laurent Journot,
    • Marc Laburthe,
    • Joseph R. Pisegna,
    • Stephen R. Rawlings,
    • Patrick Robberecht,
    • Sami I. Said,
    • Sunil P. Sreedharan,
    • Stephen A. Wank,
    • and James A. Waschek
    International Union of Pharmacology. XVIII. Nomenclature of Receptors for Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Pharmacol Rev June 1, 1998 50:265-270
  32. Review:
    • Susanne Hollinger and
    • John R. Hepler
    Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling Pharmacol Rev September 1, 2002 54:527-559; doi:10.1124/pr.54.3.527
  33. Review:
    • Riccardo Zucchi and
    • Simonetta Ronca-Testoni
    The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol Rev March 1, 1997 49:1-52
  34. Review:
    • Arthur Christopoulos and
    • Terry Kenakin
    G Protein-Coupled Receptor Allosterism and Complexing Pharmacol Rev June 1, 2002 54:323-374; doi:10.1124/pr.54.2.323
    • O P Hamill and
    • D W McBride, Jr
    The pharmacology of mechanogated membrane ion channels. Pharmacol Rev June 1996 48:231-252
  36. Review:
    • Baljit S. Khakh,
    • Geoffrey Burnstock,
    • Charles Kennedy,
    • Brian F. King,
    • R. Alan North,
    • Philippe Séguéla,
    • Mark Voigt,
    • and Patrick P. A. Humphrey
    International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits Pharmacol Rev March 1, 2001 53:107-118
    • H Ruskoaho
    Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev December 1992 44:479-602
    • M J Owens and
    • C B Nemeroff
    Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev December 1991 43:425-473
  39. Article:
    • Giorgio Minotti,
    • Pierantonio Menna,
    • Emanuela Salvatorelli,
    • Gaetano Cairo,
    • and Luca Gianni
    Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol Rev June 2004 56:185-229; doi:10.1124/pr.56.2.6
  40. Review:
    • Elliott Middleton, Jr.,
    • Chithan Kandaswami,
    • and Theoharis C. Theoharides
    The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer Pharmacol Rev December 1, 2000 52:673-751
    • D B Bylund,
    • D C Eikenberg,
    • J P Hieble,
    • S Z Langer,
    • R J Lefkowitz,
    • K P Minneman,
    • P B Molinoff,
    • R R Ruffolo, Jr,
    • and U Trendelenburg
    International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev June 1994 46:121-136
  42. Review:
    • Mitsuhiko Yamada,
    • Atsushi Inanobe,
    • and Yoshihisa Kurachi
    G Protein Regulation of Potassium Ion Channels Pharmacol Rev December 1, 1998 50:723-757
  43. Review:
    • Bertil B. Fredholm,
    • Karl Bättig,
    • Janet Holmén,
    • Astrid Nehlig,
    • and Edwin E. Zvartau
    Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use Pharmacol Rev March 1, 1999 51:83-133
  44. Review Article:
    • Andrew T. Bender and
    • Joseph A. Beavo
    Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use Pharmacol Rev September 2006 58:488-520; doi:10.1124/pr.58.3.5
  45. Review:
    • François Marceau,
    • J. Fred Hess,
    • and Dimcho R. Bachvarov
    The B1 Receptors for Kinins Pharmacol Rev September 1, 1998 50:357-386
  46. Review:
    • S. J. Hill,
    • C. R. Ganellin,
    • H. Timmerman,
    • J. C. Schwartz,
    • N. P. Shankley,
    • J. M. Young,
    • W. Schunack,
    • R. Levi,
    • and H. L. Haas
    International Union of Pharmacology. XIII. Classification of Histamine Receptors Pharmacol Rev September 1, 1997 49:253-278
  47. Review:
    • Ilia J. Elenkov,
    • Ronald L. Wilder,
    • George P. Chrousos,
    • and E. Sylvester Vizi
    The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System Pharmacol Rev December 1, 2000 52:595-638
  48. Review Article:
    • Pál Pacher,
    • Sándor Bátkai,
    • and George Kunos
    The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol Rev September 2006 58:389-462; doi:10.1124/pr.58.3.2
    • A. H. CONNEY
    PHARMACOLOGICAL IMPLICATIONS OF MICROSOMAL ENZYME INDUCTION Pharmacol Rev September 1967 19:317-366
  50. Review:
    • Jennifer I. Macgregor and
    • V. Craig Jordan
    Basic Guide to the Mechanisms of Antiestrogen Action Pharmacol Rev June 1, 1998 50:151-196

Last updated 05/10/2012 02:30:57

Available Reports

Current Issue

  1. April 2012, 64 (2)
  1. Current Issue
  1. Alert me to new issues of Pharmacological Reviews
  • ASPET Drug Metabolism Division
Society Logo HighWire Press Logo CLOCKSS logo